CVA Family Office’s OpGen, Inc OPGN Stock Holding History

CVA Family Office’s Portfolio OPGN Stock Details OPGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-10	Closed	-$5K	–	336
2020 Q1	$5K	Buy	+10	New	+$4.18K	0.01%	276

Other funds holding OPGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Wedbush Securities Los Angeles, California $3.43B AUM 24.13% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

CVA Family Office's OPGN Position: Q2 2020 in Review

CVA Family Office sold out of OpGen, Inc (OPGN) in Q2 2020, closing a stake of 10 shares — an estimated $5K sold.

CVA Family Office first reported a position in OPGN in Q1 2020 and held it in 1 quarter. The position peaked at $5K in Q1 2020. 18 funds tracked by Wall St. Rank hold OPGN as of Q2 2020.

CVA Family Office reported no remaining OpGen, Inc position as of Q2 2020 after selling out during the quarter.
CVA Family Office sold 10 OpGen, Inc shares in Q2 2020, an estimated $5K.
CVA Family Office first reported a position in OpGen, Inc in Q1 2020 and held it in 1 quarter.
CVA Family Office's OpGen, Inc position peaked at $5K in Q1 2020.
18 funds tracked by Wall St. Rank held OpGen, Inc as of Q2 2020.

Based on CVA Family Office's 13F filing for Q2 2020, filed 31 Jul 2020.